Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy: a prospective study

Archive ouverte

Carin, Anne-Julie | Molière, Sébastien | Gabriele, Victor | Lodi, Massimo | Thiébaut, Nicolas | Neuberger, Karl | Mathelin, Carole

Edité par CCSD ; BioMed Central -

BACKGROUND: The aim of this study was the evaluation of breast MRI in determining the size and focality of invasive non-metastatic breast cancers. METHODS: The prospective, single-centre study conducted in 2015 compared preoperative MRI with histological analysis of mastectomy. RESULTS: One hundred one mastectomies from 98 patients were extensively analysed. The rates of false-positive and false-negative MRI were 2 and 4% respectively. The sensitivity of breast MRI was 84.7% for the detection of all invasive foci, 69% for single foci and 65.7% for multiple foci. In the evaluation of tumour size, the Spearman rank correlation coefficient r between the sizes obtained by MRI and histology was 0.62. The MRI-based prediction of a complete response to neoadjuvant chemotherapy was 75%. DISCUSSION: MRI exhibits high sensitivity in the detection of invasive breast cancers. False positives were linked to the inflammatory nature of the tumour bed. False negatives were associated with small or low-grade tumours and their retro-areolar location. The size of T1 tumours was overestimated by an average of 7%, but MRI was the most efficient procedure. The sensitivity of MRI for the diagnosis of unifocal tumours was higher than that for multifocal sites. Our study confirmed the positive contribution of preoperative MRI for invasive lobular carcinomas and complete response predictions after neoadjuvant chemotherapy.

Suggestions

Du même auteur

A novel machine learning-derived decision tree including uPA/PAI-1 for breast cancer care

Archive ouverte | Reix, Nathalie | CCSD

International audience. Abstract Background uPA and PAI-1 are breast cancer biomarkers that evaluate the benefit of chemotherapy (CT) for HER2-negative, estrogen receptor-positive, low or intermediate grade patients...

From free‐text electronic health records to structured cohorts: Onconum, an innovative methodology for real‐world data mining in breast cancer

Archive ouverte | Simoulin, Antoine | CCSD

A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression

Archive ouverte | Reix, Nathalie | CCSD

Purpose: We explored the clinical utility of human epidermal growth factor receptor-2 extracellular domain (HER2/ECD) in patients treated for an invasive breast cancer with HER2 overexpression.Methods: We prospectively studied HER...

Chargement des enrichissements...